LAB is known for its capability to produce a variety of antimicrobial agents that can inhibit the growth of pathogenic bacteria. In 1988, the FDA approved the use of nisin and pediocin, a bacteriocin produced from
Lactococcus lactis and
Pediococcus sp. as preservatives for application in the food industry. Nisin and pediocin have been successfully commercialized widely
[7][1]. In addition to nisin and pediocin, a bacteriocin from
Enterococcus sp. namely enterocin has also gained significant academic interest following the research conducted on the effectiveness of antimicrobial agents produced by this species for use in food as a preservative. Ben Braïek et al.
[17][2] stated that enterocin produced by
Enterococcus sp. has high anti-listerial properties due to the bacteriocins produced by
Enterococcus species being mostly classified as class III. It has a C-terminal disulfide bridge that stabilizes the posterior fold in the structure, which is crucial in enhancing the antimicrobial activity of the species
[18][3]. In a study conducted by Fathizadeh et al.
[19][4], recombinant bacteriocin, enterocin A and colicin E1 (ent A-col E1) exhibited antibacterial characteristics against both Gram positive and negative bacteria. Enterocin 12a produced by
E. faecium was able to inhibit the growth of pathogens, such as
Salmonella enterica, Shigella flexneri, Vibrio cholerae, E. coli and
L. monocytogenes [20][5]. Several studies have reported the effectiveness of bacteriocin produced by LAB in inhibiting the growth of
L.monocytogenes as shown in (
Table 21). LAB are mainly from the genus of
Enterococcus (
E. lactis Q1,
E. lactis 4CP3,
E. faecalis),
Lactobacillus (
L. paracasei,
L. plantarum,
L. sakei,
L. reuteri), and
Pediococcus. Most of the bacteriocins produced by these LAB were able to inhibit the growth of
L. monocytogenes. Based on
Table 21, the treatment of
E. lactis 4CP3 (enterocin A, B, P), and
E. faecalis (enterocin AS-48) against
L. monocytogenes resulted in growth inhibition activity as reported by Ben Braïek et al.
[17,21][2][6] and Sparo et al.
[22][7]. Meanwhile, enterocin P produced by
E. lactis Q1 reportedly exhibited antimicrobial activity, as observed in the stunted growth of
L. monocytogenes after 7 days of treatment as compared to the untreated sample
[23][8]. Paracin C by
Lactobacillus paracasei, Plantaricin (EF, W, JK, S) produced by
Lactobacillus plantarum and bacteriocins produced by
Lactobacillus sakei,
L. reuteri,
L. plantarum,
L. fermentum inhibited the growth of
L. monocytogenes while the treatment of Sakacin G produced by
Lactobacillus sakei resulted in a decrease in the number of
L. monocytogenes cells on roasted meat
[24][9]. In addition, pediocin produced by
Pediococcus sp. was found to exert broad spectrum antimicrobial activity against
L. monocytogenes [25][10].
29]. On the other hand, it has been reported in some cases that the use of cell-free supernatant on raw meat can potentially reduce the antimicrobial activity of bacteriocin due to the protein degradation that takes place when the supernatant is absorbed into the meat matrix
[2][17]. Thus, Silva et al.
[45][34] and, Borges and Teixeir
[46][35] have suggested an alternative method by incorporating the purified or semi-purified bacteriocin in packaging material to increase the activity and stability of the bacteriocin in complex food systems. Referring to
Table 32, enterocin A and B from E. faecium were incorporated into an alginate film, which is one of the packaging techniques used for fermented dried sausages, minced pork, and ham
[36][23].